Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH)

4.52
Delayed Data
As of Dec 09
 -0.11 / -2.38%
Today’s Change
3.11
Today|||52-Week Range
10.79
-54.94%
Year-to-Date
No recent news for Tetraphase Pharmaceuticals Inc.

Today’s Trading

Previous close4.63
Today’s open4.65
Day’s range4.51 - 4.86
Volume778,923
Average volume (3 months)370,778
Market cap$170.9M
Dividend yield--
Data as of 4:00pm ET, 12/09/2016

Growth & Valuation

Earnings growth (last year)+5.22%
Earnings growth (this year)+19.49%
Earnings growth (next 5 years)+5.00%
Revenue growth (last year)+28.45%
P/E ratioNM
Price/Sales30.26
Price/Book0.83

Competitors

 Today’s
change
Today’s
% change
AGTCApplied Genetic Tech...+0.03+0.26%
ABUSArbutus Biopharma Co...+0.10+3.17%
OCXOncoCyte Corp+0.05+0.82%
SNDXSyndax Pharmaceutica...-0.45-4.98%
Data as of 4:00pm ET, 12/09/2016

Financials

Next reporting dateMarch 9, 2017
EPS forecast (this quarter)-$0.56
Annual revenue (last year)$11.7M
Annual profit (last year)-$83.2M
Net profit margin-711.87%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO &
Class II Director
Guy MacDonald
Principal Financial &
Accounting Officer
Christopher Watt
Corporate headquarters
Watertown, Massachusetts

Forecasts


Search for Jobs